-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EBn0atS4imXkRaIEyDmuRor4FKItmKx1BeJy8NOshXYEfh9GaJHUEP99w2VCI4Sl EvKOYVMPcExT7/rOB0JA9A== 0000942443-97-000002.txt : 19970106 0000942443-97-000002.hdr.sgml : 19970106 ACCESSION NUMBER: 0000942443-97-000002 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970103 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACOPEIA INC CENTRAL INDEX KEY: 0001002388 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 330557266 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-44599 FILM NUMBER: 97500635 BUSINESS ADDRESS: STREET 1: 101 COLLEGE RD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6094523600 MAIL ADDRESS: STREET 1: 101 COLLEGE RD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SCHERING CORP CENTRAL INDEX KEY: 0000942443 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 221261880 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL RD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 2018227000 MAIL ADDRESS: STREET 1: ONE GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 SC 13D/A 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Pharmacopeia, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 71713B104 (CUSIP Number) William J. Silbey, Esq. Schering-Plough Corporation One Giralda Farms Madison, NJ 07940-1000 (201) 822-7000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 21, 1995 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Statement because of Rule 13d-1(b)(3) or (4), check the following: _____ Check the following box if a fee is being paid with this Statement: ______ SCHEDULE 13D CUSIP No. 71713B104 (1) NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Schering Corporation (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) _____ (b) _____ (3) SEC USE ONLY (4) SOURCE OF FUNDS WC (5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) _____ (6) CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey (7) SOLE VOTING POWER NUMBER OF SHARES 764,248 BENEFICIALLY OWNED BY EACH REPORTING (8) SHARED VOTING POWER PERSON WITH None (9) SOLE DISPOSITIVE POWER 764,248 (10) SHARED DISPOSITIVE POWER None (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 764,248 (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* _____ (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 7.0% (14) TYPE OF REPORTING PERSON* CO * SEE INSTRUCTIONS BEFORE FILLING OUT! This Amendment No. 1 amends the Statement on Schedule 13D filed with the Securities and Exchange Commission on December 22, 1995 by Schering Corporation (the "Schedule 13D"). This Amendment No. 1 is filed with respect to the shares of common stock, par value $0.0001 per share (the "Common Stock") of Pharmacopeia, Inc., a Delaware corporation (the "Issuer"). The following amendments to Items 3 and 5(a) of the Schedule 13D are hereby made. Item 3. Source and Amount of Funds or Other Consideration. Item 3 of the Schedule 13D is hereby amended in its entirety to read as follows: "The aggregate amount of funds required for the purchase of 764,248 shares of the Issuer's Common Stock was $20 million. The Reporting Person obtained such funds from working capital." Item 5. Interest in Securities of the Issuer. Item 5(a) of the Schedule 13D is hereby amended in its entirety to read as follows: "(a) According to the Issuer's Quarterly Report on From 10-Q for the period ended September 30, 1996, 10,976,462 shares of Common Stock were issued and outstanding as of October 31, 1996. The Reporting Person is the beneficial owner of 764,248 shares of Common Stock, representing 7.0% of the outstanding shares of Common Stock." SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct. Dated: January 2, 1996 SCHERING CORPORATION By: /s/ William J. Silbey William J. Silbey Secretary 25711-1/25714-1 (Edgar) -----END PRIVACY-ENHANCED MESSAGE-----